Verde Bio EV/EBITDA
What is the EV/EBITDA of Verde Bio?
The EV/EBITDA of Verde Bio Holdings, Inc. is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Finance sector on OTC compared to Verde Bio
What does Verde Bio do?
Verde Bio Holdings, Inc. engages in the oil and gas exploration and investment business. It has mineral and royalty interests in various properties. The company was formerly known as Appiphany Technologies Holdings Corp. and changed its name to Verde Bio Holdings, Inc. in May 2020. Verde Bio Holdings, Inc. was incorporated in 2010 and is based in Frisco, Texas.
Companies with ev/ebitda similar to Verde Bio
- Medlab Clinical has EV/EBITDA of N/A
- Altima Resources has EV/EBITDA of N/A
- Deccan Gold Mines has EV/EBITDA of N/A
- Ocuphire Pharma has EV/EBITDA of N/A
- CURE Pharmaceutical has EV/EBITDA of N/A
- D2 L Inc has EV/EBITDA of N/A
- Verde Bio has EV/EBITDA of N/A
- Longboat plc has EV/EBITDA of N/A
- Truett-Hurst has EV/EBITDA of N/A
- SOBR SAFE has EV/EBITDA of N/A
- Spartan Acquisition has EV/EBITDA of N/A
- Achiko AG has EV/EBITDA of N/A
- Family Insights has EV/EBITDA of N/A